We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $566M
1-Year Est. Return 197.74%
This Fund
S&P 500
This Quarter Est. Return
+96.59%
1 Year Est. Return
+197.74%
3 Year Est. Return
+371.51%
5 Year Est. Return
+473.27%
10 Year Est. Return
AUM
$566M
AUM Growth
+$191M
Cap. Flow
-$25.1M
Cap. Flow %
-4.43%
Top 10 Hldgs %
65.92%
Holding
98
New
12
Increased
27
Reduced
22
Closed
5

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$5.33M
2
HELP
Cybin Inc
HELP
+$3.72M
3
MSFT icon
Microsoft
MSFT
+$3.33M
4
IMRX icon
Immuneering
IMRX
+$3.28M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$1.99M

Top Sells

Rank Stock Value
1
MU icon
Micron Technology
MU
+$37.5M
2
LLY icon
Eli Lilly
LLY
+$5.72M
3
CSCO icon
Cisco
CSCO
+$1.57M
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$1.52M
5
IONS icon
Ionis Pharmaceuticals
IONS
+$1.39M

Sector Composition

Rank Sector Weight
1 Miscellaneous 38.15%
2 Technology 31.31%
3 Healthcare 17.63%
4 Communication Services 4.62%
5 Consumer Discretionary 4.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QQQ icon
1
PUT
Invesco QQQ Trust
QQQ
$488B
$142M 25.13%
193,100
+67,100
+53% +$46.2M
MU icon
2
Micron Technology
MU
$1.1T
$115M 20.4%
100,000
-50,000
-33% -$37.5M
GOOG icon
3
Alphabet (Google) Class C
GOOG
$4.1T
$19.1M 3.37%
54,000
-3,000
-5% -$1.07M
SPY icon
4
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$808B
$18.7M 3.3%
25,000
+3,500
+16% +$2.54M
AMD icon
5
Advanced Micro Devices
AMD
$843B
$16.8M 2.98%
29,000
MU icon
6
CALL
Micron Technology
MU
$1.1T
$14.4M 2.55%
+12,500
New +$9.37M
AMZN icon
7
Amazon
AMZN
$2.77T
$14.1M 2.5%
59,250
+21,250
+56% +$5.33M
ARGX icon
8
argenx
ARGX
$61.6B
$13.2M 2.33%
14,200
-450
-3% -$371K
CRVS icon
9
Corvus Pharmaceuticals
CRVS
$1.09B
$9.52M 1.68%
637,500
HELP
10
Cybin Inc
HELP
$948M
$9.49M 1.68%
1,434,988
+743,000
+107% +$3.72M
TEVA icon
11
Teva Pharmaceuticals
TEVA
$43.2B
$8.62M 1.52%
254,500
-45,500
-15% -$1.52M
MRVL icon
12
Marvell Technology
MRVL
$212B
$8.19M 1.45%
27,500
IAU icon
13
iShares Gold Trust
IAU
$64.4B
$7.55M 1.33%
100,000
BAC icon
14
Bank of America
BAC
$438B
$6.81M 1.2%
119,500
REGN icon
15
Regeneron Pharmaceuticals
REGN
$80.5B
$5.77M 1.02%
9,250
ET icon
16
Energy Transfer Partners
ET
$74.2B
$5.75M 1.02%
300,500
VRTX icon
17
Vertex Pharmaceuticals
VRTX
$131B
$5.71M 1.01%
11,500
+4,500
+64% +$1.99M
GLD icon
18
SPDR Gold Trust
GLD
$147B
$5.16M 0.91%
14,000
+2,000
+17% +$829K
C icon
19
Citigroup
C
$233B
$5.04M 0.89%
36,000
NAMS icon
20
NewAmsterdam Pharma
NAMS
$2.73B
$4.78M 0.84%
141,000
-19,600
-12% -$646K
GDX icon
21
VanEck Gold Miners ETF
GDX
$29.5B
$4.72M 0.83%
62,500
INCY icon
22
Incyte
INCY
$24.6B
$4.7M 0.83%
41,500
CSCO icon
23
Cisco
CSCO
$442B
$4.7M 0.83%
40,000
-15,000
-27% -$1.57M
BIDU icon
24
Baidu
BIDU
$31.2B
$4.57M 0.81%
40,000
-1,000
-2% -$124K
ORCL icon
25
Oracle
ORCL
$433B
$4.47M 0.79%
30,500
+2,000
+7% +$362K

Similar funds

DCF Advisers's Q2 2026 Portfolio in Review

As of Q2 2026, DCF Advisers held 98 positions worth $566M, up 51% from $375M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

DCF Advisers withdrew a net $25.1M in Q2 2026, closing 5 positions and reducing 22 holdings. Its most notable exit was Synopsys, an estimated $496K position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, down from 38% a quarter earlier, followed by Technology and Healthcare.

Against the trend, DCF Advisers opened a new position in MarineMax worth $2.11M.

  • DCF Advisers's largest Q2 2026 buy was MarineMax: 57,500 shares worth $2.11M.
  • DCF Advisers added most to Amazon in Q2 2026, an estimated $5.33M increase.
  • DCF Advisers's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $37.5M.
  • DCF Advisers fully exited Synopsys in Q2 2026, selling an estimated $496K.
  • DCF Advisers's ten largest holdings make up 66% of its $566M portfolio in Q2 2026.
  • DCF Advisers opened 12 new positions and closed 5 in Q2 2026.
  • DCF Advisers's portfolio value rose 51% quarter-over-quarter to $566M.

Based on DCF Advisers's 13F filing for Q2 2026, filed 10 Aug 2026.